CD8+ T cells are central to the anti-tumour response by producing INFγ and granzyme B. Therefore, manipulating cholesterol metabolism to enhance CD8+ T cell effector responses can be beneficial in cancer treatment (Figure 2). This evidence concerns the gene CD8A and cancer.